Phase II multi-centre, non randomized, open label study of nivolumab in combination with ipilimumab as first line in adults patients with metastatic uveal melanoma. GEM 14-02 A.J. Rullan Iriarte,Salvador Martín-Algarra,L. de la Cruz Merino,D. Rodriguez Abreu,Enrique Espinosa,A. Berrocal,R. López Castro,T. Curiel,P. Luna, A. Lorenzo,Josep M. PiulatsANNALS OF ONCOLOGY（2016）引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
